LONDON, Aug. 13 (Xinhua) -- A marker in the blood could help predict the risk that a person has of developing kidney cancer, according to a study released on Monday by Cancer Research UK. The research team found that measuring levels of a protein molecule in the blood, called KIM-1, ...
The Australian research at Flinders University has discovered a blood serum microRNA biomarker signature for oropharyngeal squamous cell carcinoma, recently reported in a new study in theJournal of Translational Medicine. The signature might have potential for the detection of other squamous mucosal Head ...
伪-Enolase as a blood marker for renal cancer for use in monitoring during and/or after treatment for renal cancer.Matsuo, EiichiKaneko, NaokiWatanabe, MakotoNishimura, OsamuOkamura, NoboruGotoh, Akinobu
"The discovery of abiraterone was an important step forward for patients with advanced prostate cancer, but we know it doesn't work for all men, and we've been searching for a marker that will tell us in advance which men will benefit. We're delighted to have developed a test that appea...
marker is further confounded by poor interobserver agreement in the interpretation of immune cell expression [43]. Regarding sample selection, if more than one tissue block is available for a given tumour, the most representative sample should be tested. More than one block may be tested when ...
clinically validate a test for BRCA detection [71]. In 2019, the objective of the trial was expanded to include the diagnosis of invasive cancer, including haematologic cancer (HC), within one year after the first study blood draw. It is an observational, prospective study (n = 99,480...
[33]. Malur et al., reported that 155 of 235 patients were positive (sensitivity of 65.9%) and 144 of 204 healthy controls were negative (specificity of 70.6%) [34]. The sensitivity of the TACT assay was significantly higher than the sensitivity of the standard blood tumor marker assays ...
[137] developed multiplex drop-off droplet digital PCR (ddPCR) assays, targeting four BC microsatellites and showing that MSI can be an actionable marker for immunotherapy [137]. BC diagnosis using predefined microsatellite panels is still a challenge, unlike most tumor types that need a limited ...
Hi Judy, I have a genetic marker, fibrinogen which causes inflammation. I have not found a way to over turn this or at least bring the blood results down from over 509 to a safer level below 300. I’ve asked Ty and many of the specialists associated with this series and received no ...
Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Am J Surg Pathol. 2008;32:572–80. Article PubMed Google Scholar Stacchiotti S, Sommer J, Ares C, Blay JY, Bolle S, ...